Clinical Trials Logo

Clinical Trial Summary

The aim of this trial is to demonstrate the efficacy and safety of STYLAGE® XXL in augmenting the chin volume among Chinese adults. Subjects will be randomized either to the treatment group or the control group in a 4:1 ratio The superiority of STYLAGE® XXL against no-treatment control in chin volume augmentation will be verified together with assessments of the safety profiles.


Clinical Trial Description

This study is a no-treatment controlled, prospective, randomized, multi-center, evaluator-blinded study, in Chinese subjects seeking for chin volume augmentation. 150 subjects will be randomized either to the treatment group or the control group in a 4:1 ratio (120 subjects in the treatment group and 30 subjects in the control group). Subjets assigned to the treatment group will receive STYLAGE® XXL at enrollment. Subjects assigned to the control group will not receive treatment at enrollment; however, at 6 month visit, subjects who are still eligible for chin augmentation with STYLAGE® XXL will be treated STYLAGE® XXL superiority will be demonstrated against no-treatment control in augmenting the chin volume, as measured by blinded evaluator at 6-month ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05009381
Study type Interventional
Source Laboratoires Vivacy
Contact
Status Completed
Phase N/A
Start date September 10, 2021
Completion date August 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03108742 - Randomized Control Study of Dermal Staples vs Subcuticular Sutures on Postoperative Scar After Thyroidectomy N/A